These are all critical consideration for sponsors, as failing to conduct trials in accordance with GCP and other applicable regulations can lead to regulatory authorities rejecting data that is generated to support new treatments and regulatory applications, as well as penalties for the company ranging from monetary fines to a negative impact on reputation.
As such, proactively planning for regulatory considerations for the full trial lifecycle, including the key examples of DCT solutions below, is a worthy investment of resources and budget.
